Global Home Infusion Therapy Market to Reach $63.5 Billion by 2030
The global market for Home Infusion Therapy estimated at US$38.3 Billion in the year 2022, is projected to reach a revised size of US$63.5 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2022-2030. Infusion Pumps, one of the segments analyzed in the report, is projected to record 5.2% CAGR and reach US$29.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Intravenous Sets segment is readjusted to a revised 6.7% CAGR for the next 8-year period.The U.S. Market is Estimated at $10.4 Billion, While China is Forecast to Grow at 11.2% CAGR
The Home Infusion Therapy market in the U.S. is estimated at US$10.4 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$15 Billion by the year 2030 trailing a CAGR of 11.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.2% and 5.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.Select Competitors (Total 36 Featured) -
- Baxter International, Inc.
- Becton, Dickinson and Company (BD)
- Braun Melsungen AG
- BriovaRx Infusion Services
- Caesarea Medical Electronics
- CareFusion Corporation
- Cosmed
- Eli Lilly and Company
- Eitan Medical
- Fresenius Kabi
- ICU Medical, Inc.
- JMS Co. Ltd.
- Lincare Holdings, Inc.
- Moong, Inc.
- Smiths Medical
- Terumo Corporation
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Baxter International, Inc.
- Becton, Dickinson and Company (BD)
- Braun Melsungen AG
- BriovaRx Infusion Services
- Caesarea Medical Electronics
- CareFusion Corporation
- Cosmed
- Eli Lilly and Company
- Eitan Medical
- Fresenius Kabi
- ICU Medical, Inc.
- JMS Co. Ltd.
- Lincare Holdings, Inc.
- Moong, Inc.
- Smiths Medical
- Terumo Corporation
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 92 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 38.3 Billion |
Forecasted Market Value ( USD | $ 63.5 Billion |
Compound Annual Growth Rate | 6.5% |
Regions Covered | Global |